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a  b  s  t  r  a  c  t
Background:  Novel  3-dimensional  echocardiography  with  speckle  tracking  imaging  (3D-STE)  may  have
advantages  in  assessing  left  ventricular  (LV)  volume  through  a cardiac  cycle.  The  feasibility  of 3D-STE
may  be  affected  by image  quality  and  LV  morphology.
Methods  and results:  We  studied  64 patients  (38 men,  age  55 ±  12  years)  who  underwent  cardiac  magnetic
resonance  imaging  (CMRI)  and 3D-STE  on the same  day.  LV end-diastolic  volume  (EDV)  and  end-systolic
volume  (ESV)  were  measured  by both  modalities.  Imaging  qualities  were  quantiﬁed  in each  of  6  LV  seg-
ments  by  an  imaging  quality  score  (IQS)  of 1–3, and  scores  were  averaged  (mean  IQS)  at end-diastole  and
end-systole.  Compared  to CMRI,  3D-STE  showed  a tendency  to  underestimate  LV  volume  measurements,
but not  signiﬁcantly  (EDV:  bias  = −18  ±  37  ml; ESV:  bias  = −10 ± 34  ml),  and  measurements  correlated
well with  those  by  CMRI  (EDV:  R = 0.80, ESV:  R  =  0.86,  ejection  fraction:  R =  0.75,  p < 0.001).  The  absolute
differences  of  LVEDV  and  ESV between  3D-STE  and  CMRI correlated  signiﬁcantly  with  mean  IQS (LVEDV,
R  =  −0.35, p = 0.005;  LVESV,  R  =  −0.30, p = 0.02).  Based  on  the  medium  value  of  LVEDV  by  CMRI  (127 ml),
subjects  were classiﬁed  into  the small  (<127  ml)  and  large  LVEDV  (127  ml)  groups.  In  the large  LVEDV
group,  mean  IQS  signiﬁcantly  correlated  with the  absolute  differences  of  LVEDV  (mean  IQS,  r  =  −0.45,
p  =  0.01),  despite  no  signiﬁcant  correlation  in  the  small  LVEDV  group.
Conclusion: 3D-STE  could  measure  LV  volume  as well  as CMRI, however,  its accuracy  depends  on  the
quality  of the  acquired  image  and  particularly  on  enlargement  of  the  left  ventricle.
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One limitation of conventional 2-dimensional (2D) echocardi-
graphy is the “through plane” phenomenon. Because the entire
eart is moving in various directions at the same time, the ﬁxed
ross-sectional echo window permits only faulty measurements
1–5]. In contrast, 3-dimensional (3D) echocardiography may  com-
ensate for this limitation by obtaining 3D information [6–8]. We
ave previously validated left ventricular (LV) strain measurements
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by 3D speckle tracking echocardiography (3D-STE) in an animal
model [9]. In principle, however, acquiring and analyzing 3D data
requires more computational resources, and that gives rise to more
restrictions in spatial and temporal resolution compared with 2D
echocardiography. Accordingly, this may  cause substantially inad-
equate precision. Nesser et al. [10] validated the ability of 3D-STE
to measure LV volume in a comparison study with cardiac mag-
netic resonance imaging (CMRI). They reported favorable accuracy
and reproducibility over measurements by 2D echocardiography,
but they limited their analysis to subjects with adequate imaging
quality. However, it is not always possible to expect acceptable
imaging quality, which may  affect actual results of measurements
in the real-world clinical setting. Therefore, the aims of this study
of consecutive patients who  underwent CMRI were: (1) to com-
pare LV volume measurements between 3D-STE and CMRI and (2)
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o evaluate factors that relate to the differences of LV volume mea-
urements between 3D-STE and CMRI.
ethods
tudy subjects
This study enrolled 68 consecutive patients who underwent
chocardiographic examination within 1 h after CMRI examination.
he intrinsic cardiac rhythm in all patients was sinus rhythm. The
tudy was approved by the local research ethics committee, and all
atients gave their written informed consent.
onventional LV volume measurements
All echocardiographic data was obtained with an Aplio ArtidaTM
chocardiographic system (Toshiba Medical Systems, Tochigi,
apan). In conventional 2D echocardiographic examinations, LV
nd-diastolic volume (LVEDV) and end-systolic volume (LVESV)
ere measured by the bi-plane modiﬁed Simpson’s method [11].
V volume measurements by 3D-STE
All 3D echocardiographic examinations also were performed
ith the ArtidaTM ultrasound system. Full-volume electrocardio-
ram (ECG)-gated 3D data sets were acquired from apical positions
sing a matrix array 2.5-MHz transducer. To obtain these data
ets, 6 sectors were scanned and automatically integrated into a
ide-angle (70◦ × 70◦) pyramidal data image covering the entire
V. Frame rate of each image was set at approximately 30 Hz.
The data were stored and transferred to a personal computer-
ased workstation for off-line analysis. The images were analyzed
ith the Advanced Cardiology Package software (Toshiba Medical
ystems Co.) speciﬁcally designed for analysis of data acquired with
he ArtidaTM system. A representative case is shown in Fig. 1. The
D data sets were displayed as multiplanar reconstruction (MPR)
mages corresponding to apical 2-chamber and 4-chamber views
nd 3 short-axis levels. In the MPR  display, the ventricular long
xis was adjusted so that the longest chamber lengths for the 4-
hamber view in panel A and 2-chamber view in panel B of Fig. 1
ere obtained. After adjustment of the planes, the endocardial
ontours were traced for the respective views. Each contour was
eriﬁed in the reconstructed short-axis views at the levels of the
pical, mid, and basal sections in panels C3, C5, and C7, respec-
ively, so that the contour exactly traced the endocardium. The
apillary muscles were not included in the LV cavity. The 3D-STE
ystem automatically followed the transformation of the left ven-
ricle during the measured cardiac cycle, and the transitions of the
V contour were veriﬁed visually throughout the cardiac cycles.
f this procedure failed to track the transition of the wall motion,
he procedure was repeated until valid tracings were obtained.
V volume was measured directly from the tracked 3D endocar-
ial surface information obtained by 3D-STE, and volumes were
btained from a single cardiac cycle with no assumptions about LV
tructure. LVEDV was deﬁned as the LV volume at end-diastole, and
VESV was deﬁned as the minimum LV volume measured during
he cardiac cycle. LV ejection fraction (LVEF, %) was calculated by
he formula (LVEDV − LVESV) × 100/LVEDV [9].
uantiﬁcation of 3D-STE imaging quality
3D-STE imaging quality was classiﬁed into 3 states according to
he feasibility of determining segmental endocardial continuity by
eﬁning an imaging quality score (IQS). Score 3 indicates that the
ontour is clearly visible and easily traced, score 2 indicates that
he contour is not clearly visible but can be determined from thediology 63 (2014) 230–238 231
echo information of adjacent tissue, and score 1 indicates that the
contour can hardly be seen. In Fig. 1, the apical 2-chamber view
was divided into 3 combined regions: ﬁrst, combined with basal
and mid  anterior walls; second, apical anterior and apical inferior
walls, and third, basal and mid  inferior walls. Similarly, in the apical
4-chamber view, the image was divided into 3 combined regions:
ﬁrst, combined with basal and mid  lateral walls; second, apical lat-
eral and apical septal walls; and third, basal and mid  septal walls.
Each region was evaluated at the end-diastolic and end-systolic
phases by two  different experienced observers (R.K., Y.S.). Image
quality was calculated as the mean total score (mean IQS) of the
scores assessed at end-diastole and at end-systole. An example of
scoring at end-diastole is shown in Fig. 2.
CMRI acquisition
CMRI examinations were performed with a 1.5-T superconduct-
ing unit (NT/Intera 1.5 T Master R12; Philips, Best, Netherlands)
with a phased-array cardiac coil. First, ECG-gated cine mode images
with a steady-state free precession (balanced turbo ﬁeld echo) were
obtained in long- and short-axis views of the left ventricle at 10-
mm slice thickness without an intersection gap. The repetition time
and echo time were 2.845 and 1.4225 ms,  respectively, the ﬂip angle
was 70◦, and the imaging matrix was  160 × 229. Acquisition time
was from 10 to 16 s long during breath holding.
CMRI analysis
The images obtained by the CMRI scanner were stored on an
optical disk in DICOM format. The data were analyzed off-line with
a personal computer-based system using commercial analysis soft-
ware (ViewForum R5.1V1L1; Philips). The software loaded serial
short-axis sections of the left ventricle, and the ﬁrst basal slice,
which showed the circular LV wall construction throughout the
cardiac cycle, and the last apical slice, which showed the LV cavity,
were set manually. In the end-diastolic frame of the ﬁrst slice, the
inner contour was manually traced, and the software automatically
recognized the contour of subsequent frames. The same procedure
was performed on each slice until the ﬁnal apical slice. If incorrect
tracing was  apparent, the contour was corrected manually in the
appropriate frames. The intraventricular volume was calculated as
the total sum of the product of the area within each contour and the
thickness between the each slice (i.e. 10 mm). The EDV was set as
the volume at the time of R-wave onset on the ECG, and the ESV was
set as the smallest volume measured throughout the cardiac cycle.
These data were used as the reference values for echocardiographic
measurements.
Reproducibility analysis
Reproducibility of the measurements from both modalities was
determined by analyzing random samples from 10 cases by the
same investigator at least 1 month after the ﬁrst analysis to deter-
mine intra-observer variability and by a separate investigator (H.N.)
to determine inter-observer variability. The other investigator was
blinded to the results of the ﬁrst observer. Reproducibility was ana-
lyzed as the coefﬁcient of variability deﬁned as the ratio of the
standard deviation (SD) and the mean of absolute readings for each
echocardiographic parameter.
Statistical analysesResults are expressed as number or the mean value ± SD. The
echocardiographic data were compared with the data obtained
from CMRI as the reference. The data were statistically analyzed
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Fig. 1. Left ventricular volume measurement with 3-dimensional speckle tracking echocardiography and division of the left ventricular wall in assessing imaging quality
score.  In the multiplanar reconstruction display, panel A (top center) and panel B (top right) show apical 4-chamber and 2-chamber views of the left ventricle, and panels
C3  (top left), C5 (middle left), and C7 (bottom left) show short-axis images of the left ventricle at the level of the apex, mid  ventricle, and base, respectively. Labeling and
positioning of the panels are controlled by the vendor and are shown as originally output. 4ch, 4-chamber view; 2ch, 2-chamber view. See text for details.
Fig. 2. Representative cases for assessing imaging quality score (IQS). In the left images, the end-myocardial border of the septal region in panel A and the anterior region in
panel  B (as deﬁned in Fig. 1) are hardly seen and are thus scored as 1. In contrast, in the right image, the end-myocardial border of the anterior, apical, and inferior regions in
panel  B and the lateral and septal regions in panel A can be easily determined and are scored as 3, whereas the end-myocardial border of the apical region in the 4-chamber
view  can be determined by the adjacent contour and is scored as 2.
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Table  1
Clinical characteristics and echocardiographic data.
Sex (female/male), n 26/38
Age, years 55 ± 12 (range 17–80)
Dilated cardiomyopathy, n 17
Secondary myocardial diseases, n 14
Hypertrophic cardiomyopathy, n 12
Ischemic heart disease, n 8
Arrhythmia diseases, n 7
Hypertensive heart disease, n 4
Aortic stenosis, n 2
Heart rate, bpm 64 ± 13
End-diastolic dimension, mm 51 ± 9.7
End-systolic dimension, mm 38 ± 12
Interventricular septum thickness, mm 10 ± 5.8
Posterior wall thickness, mm 9.4 ± 2.3
Values are n or mean ± SD (range)
Table 2
Volumetric measurements by CMRI, 2D echocardiography, and 3D-STE.
CMRI 2D echocardiography 3D-STE
LVEDV (ml) 144 ± 60 113 ± 47* 125 ± 53
LVESV (ml) 89 ± 64 58 ± 43* 78 ± 49
EF  (%) 44 ± 19 52 ± 17*,† 43 ± 15
Values are mean ± SD. CMRI, cardiac magnetic resonance imaging; 3D-STE,
three-dimensional speckle tracking echocardiography; LVEDV, left ventricular end-

































Relations with differences in volume measurements.
Variables LVEDV LVESV
r p r p
Age – 0.71 – 0.2
Body mass index – 0.26 – 0.2
Heart rate – 0.76 – 0.7
LVEDV by CMRI 0.41 0.001 0.52 <0.001
LVESV by CMRI 0.39 0.002 0.52 <0.001
LVEF by CMRI −0.23 0.06 −0.42 <0.001
LVDd by 2D echo 0.26 0.05 0.31 0.01
LVDs by 2D echo – 0.38 – 0.8
IQS  at end-diastole
Mean −0.35 0.005 −0.27 0.03
Anterior region – 0.22 – 0.12
Apical region in 2ch −0.30 0.02 – 0.08
Inferior region −0.31 0.01 – 0.16
Lateral region – 0.51 – 0.81
Apical region in 4ch −0.33 0.008 −0.28 0.03
Septal region −0.33 0.009 −0.27 0.03
IQS  at end-systole
Mean −0.30 0.02
Anterior region – 0.12
Apical region in 2ch −0.25 0.06
Inferior region −0.27 0.03
Lateral region – 0.24
Apical region in 4ch – 0.24
Septal region −0.31 0.02
LVEDV, left ventricular end-diastolic volume; CMRI, cardiac magnetic resonance
imaging; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejectionjection fraction.
* p < 0.05 vs. CMRI.
† p = 0.006 vs. 3D-STE.
y simple linear regression and by Bland–Altman analysis to deter-
ine the bias and limits of agreement between the modalities. The
igniﬁcance of the difference between the groups was  tested by
ne-way analysis of variance (ANOVA). When signiﬁcant difference
as detected, signiﬁcance was tested by Scheffé’s post hoc test.
Simple linear regression analyses were performed to assess fac-
ors that have signiﬁcant interactions with absolute differences of
olume measurements between 3D-STE and CMRI. If the absolute
ifferences of LV volume measurements between 3D-STE and CMRI
ere more than a 75 percentile point of the absolute differences,
he measurements by 3D-STE were deﬁned as data with signiﬁcant
rror. The area under the receiver-operating characteristics (ROC)
urve (AUC) was used to quantify the ability to predict a signiﬁ-
ant error. The best cutoff value was deﬁned as the point with the
ighest sum of sensitivity and speciﬁcity. A p-value of <0.05 was
onsidered to indicate statistical signiﬁcance. All calculations were
erformed with SPSS ver. 20 (SPSS Inc., Chicago, IL, USA).
esults
Of the 68 patients, 4 patients were excluded because of
nadequate imaging quality even in the 2D echocardiographic
xaminations. Finally, 64 patients were studied fully (Table 1).
econdary myocardial disease included cardiac sarcoidosis in 6
atients. Arrhythmia-related diseases included Brugada syndrome
n 2 patients, arrhythmogenic right ventricular cardiomyopathy in
, long QT syndrome in 1, and idiopathic ventricular tachycardia in
 patient. These 6 patients were in sinus rhythm during the CMRI
nd echocardiographic examinations.
omparisons of LV volume measurements and EF between
ethodsVolumetric measurements are summarized in Table 2. 3D-STE
howed a tendency for underestimation of LV volume measure-
ents, which did not differ signiﬁcantly from those by CMRI. In
ontrast, 2D echocardiography signiﬁcantly underestimated bothfraction; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-
systolic dimension; 2ch, apical 2-chamber view; 4ch, apical 4-chamber view; IQS,
image quality score.
LVEDV and LVESV. Consequently, LVEF by 2D echocardiography
was signiﬁcantly different from LVEF by CMRI.
Comparisons of regional IQS
The mean IQS of the 6 LV regions at end-diastole was sig-
niﬁcantly lower than the mean IQS at end-systole (2.2 ± 0.6 vs.
2.0 ± 0.5, p < 0.001), showing strong correlation between both mean
IQSs (r = 0.92, p < 0.001). IQS in each region at end-diastole and end-
systole are shown in Fig. 3. There were signiﬁcant differences in IQS
between regions at both end-diastole and end-systole. IQSs in the
septal and inferior regions were higher, whereas IQSs in the anterior
and apical regions in the 2-chamber view were lower than those of
other regions. In the comparison of corresponding regions between
end-diastole and end-systole, IQS at end-systole was signiﬁcantly
higher (p < 0.05) in all regions except for the septal region.
IQS and LV volume measurements
Correlations of the measurements by 3D-STE with those by CMRI
are shown in Fig. 4.
First, the subjects were classiﬁed into 3 groups based on tertile
points of mean IQS. The ﬁrst and second tertile IQS points at end-
diastole were 1.8 and 2.3, and those at end-systole were 2.0 and
2.5, respectively. Bland–Altman plots revealed a wide range of 95%
CI values in the ﬁrst tertile group compared to the second and third
tertile groups. Subsequently, absolute differences of volume mea-
surements between 3D-STE and CMRI were modestly correlated
with mean IQS (Fig. 5).
Related factors of differences in volume measurementsThe relations with absolute differences of volume measure-
ments are summarized in Table 3. The both absolute difference of
LVEDV and LVESV correlated with LVEDV and LVESV measured by





































pFig. 3. Imaging quality scores between left ventricu
MRI, mean IQS, and IQS in the apical and septal regions at end-
iastole.
ccuracy of LV volume measurements and the enlarged left
entricle
Based on the medium value of LVEDV by CMRI (127 ml), subjects
ere classiﬁed into the small (<127 ml)  and large LVEDV (127 ml)
roups. In the small LVEDV group, LVEDV and mean IQS did not
orrelate with the absolute differences of LVEDV. In contrast, in the
arge LVEDV group, only mean IQS signiﬁcantly correlated with the
bsolute differences of LVEDV (mean IQS, r = −0.45, p = 0.01). The
uartile points of the absolute differences of LVEDV were as fol-
ows: 25 percentile was 12.4 ml,  medium 26.0 ml; 75 percentile
as 32.7 ml,  maximum 133.7 ml  and minimum 1.0 ml.  Then, an
bsolute difference of LVEDV of ≥33 ml  was deﬁned as a signiﬁ-
ant error of LVEDV measurement by 3D-STE. In ROC analysis to
etect signiﬁcant error of LVEDV measurement, the AUC was 0.64
or LVEDV (p = 0.75), and 0.57 for mean IQS (p = 0.35). However, in
he large LVEDV group, the AUC for mean IQS was 0.73 (p = 0.02),
ith a sensitivity of 0.88 and speciﬁcity of 0.50 under the cut-off
oint of 1.5.
As for LVESV, based on the medium value of LVESV by CMRI
63 ml), subjects were classiﬁed into the small (<63 ml)  and large
VESV (≥63 ml)  groups. As with LVEDV, in the small LVESV group,
ean IQS at both end-diastole and end-systole did not correlate
ith absolute differences of LVESV, and in the large LVESV group,
ean IQS at end-systole, but not end-diastole, signiﬁcantly corre-
ated with the absolute differences of LVESV (mean IQS, r = −0.41,
 = 0.02).
The quartile points of the absolute differences of LVESV were as
ollows: 25 percentile was 7.5 ml,  medium 18.5 ml;  75 percentile
as 33.6 ml,  maximum 115.6 ml  and minimum 0.3 ml.  An absolute
ifference of LVESV of ≥33.7 ml  was deﬁned as a signiﬁcant error of
VESV measurement. In ROC analysis, the AUC to detect signiﬁcant
rror of LVESV measurement was 0.77 for LVESV (p = 0.002) with a
ensitivity of 0.69 and speciﬁcity of 0.81 under the cut-off point of
09 ml.  In contrast, the AUC was 0.63 for mean IQS (p = 0.11). In the
arge LVESV group as well, the AUC for LVESV was 0.75 (p = 0.02),
ith a sensitivity of 0.83 and speciﬁcity of 0.60 under the cut-off
oint of 116 ml;  however, the AUC was 0.62 for mean IQS (p = 0.22).gions. 4ch, 4-chamber view; 2ch, 2-chamber view.
Reliability of LVEF by 3D-STE
Correlations of LVEF by 3D-STE with those by CMRI are shown
in Fig. 4. In addition, there were no signiﬁcant relations between
absolute differences of LVEF and the variables shown in Table 3.
However, absolute differences of LVEF modestly correlated only
with an absolute difference of LVESV (r = 0.30, p = 0.01).
Reproducibility
In regard to reproducibilities of CMRI- and 3D-STE-derived
LVEDV and LVESV measurements, all inter- and intra-observer vari-
abilities were below 10%. Inter-observer variability was higher than
intra-observer variability for each measurement. The highest inter-
observer variability was that of 3D-STE-derived LVESV (9.7 ± 6.4%)
followed by CMRI-derived LVESV (8.3 ± 3.7%).
Discussion
The present study showed that 3D-STE could measure LV
volume through the cardiac cycle more accurately than could
measurement by standard 2D echocardiography. Because 3D-STE
is a novel modality that uses an endocardial tracking system to
estimate the LV border, our ﬁndings conﬁrmed the reliability of
myocardial tracking. However, as we hypothesized the accuracy
of measurements was  dependent on the quality of the acquired
images as well as on enlargement of the left ventricle.
LV volume measurement is an advantage of 3D echocardiogra-
phy. However, the system used in previous studies did not use STE
to detect the LV border [6–8]. STE was  developed as a modality for
myocardial function analysis. We previously reported a validation
study for 3D-STE in assessing regional myocardial deformation [9].
However, unlike regional myocardial strain analysis, tracking of the
entire LV endocardial border with STE has remained challenging.
Indeed, favorable accuracy and reproducibility may  be obtained by
limiting analysis to subjects with adequate imaging quality [10]. We
hypothesized that the important factor inﬂuencing the concord-
ance between LV volumes measured by CMRI and 3D-STE would be
the quality of the acquired images. In fact, LV volumes measured
by 3D-STE were signiﬁcantly affected by image quality based on
the correlations with LV volumes measured by CMRI. In addition,
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Fig. 4. Correlations of volume measurements and ejection fraction between cardiac magnetic resonance imaging (CMRI) and 3-dimensional speckle tracking echocardiography
(3D-STE): (a) left ventricular end-diastolic volume, (b) left ventricular end-systolic volume, and (c) left ventricular ejection fraction. Scatter plots in the left panels show the
correlation between the modalities. Bland–Altman plots in the right panels show the biases and limits of agreement. Lines and numbers in the right panels indicate ±95%
conﬁdence intervals and biases of the two modalities.
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Fig. 4. ( Continued )
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Fig. 4. ( Continued )









































[ig. 5. Correlations of IQS and absolute volume differences for left ventricular volum
VEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fractio
chocardiography.
ifferences in LV volume measurements between CMRI and 3D-STE
ere related to image quality, particularly in the setting of a larger
V volume. These ﬁndings suggest that since LV volume measure-
ents may  have a signiﬁcant role in assessing pathophysiology in
ardiac disease with LV remodeling, image quality should be taken
nto consideration when interpreting LV volume data from 3D-STE.
Better image quality of 3D-STE was necessary to accurately
stimate LV volume. Inadequate image quality due to the lower
patio-temporal resolution of 3D-STE is the ﬁrst concern related to
naccuracy in measurement. In particular, a lower IQS in the ante-
ior region followed by the lateral region indicates a limitation of
esolution in the peripheral regions in a 3D image as compared
ith the IQS in the septal and inferior regions, which are located
t the round center of the image. However, lower image qual-
ty in the septal and inferior regions, which should be visualized,
ay  affect the accuracy of LV volume measurements as shown in
able 3.
We showed that 3D-STE has a limitation in evaluating diseases
ith cardiac chamber enlargement. A large LV volume itself was
 strong determinant of differences in LV volume measurements
etween 3D-STE and CMRI, as correlation coefﬁcients between
D-STE and CMRI were under 1.0. However, in patients with
arger LV volume, image quality was also an independent deter-
inant of accurate LV volume measurements. The main reason
s limitation of the permitted angle to obtain 3D-pyramidal data
ets, which could strongly affect image quality of the peripheral
egions.
The present study also showed that 3D-STE had good repro-
ucibility. Reproducibility of the measurements, as indicated by
oth intra- and inter-observer variability of <10%, was  clinically
cceptable. Intra-observer variability was smaller than inter-
bserver variability, and variability of LVESV measurements was
arger than that of LVEDV measurements. The reason for the dif-
erence in reproducibility could be caused by the quite vague
eﬁnition for determining the endomyocardial contour, making it
ifﬁcult to unify the procedure between examiners. The difference
n variability could be explained by the fact that the contour of
he end-diastolic phase is determined manually, whereas that of
he end-systolic phase is the result of automated tracking of the
ontour.
[surements. CMRI, cardiac magnetic resonance imaging; IQS, imaging quality score;
ESV, left ventricular end-systolic volume; 3D-STE, 3-dimensional speckle tracking
Conclusion
In comparison with CMRI, 3D-STE was shown to be a feasible
method of quantifying LV volume. However, this novel technique
is still thought to be limited to cases in which the imaging qual-
ity is adequate, particularly in patients with a large LV volume.
These results will help clinicians to select appropriate patients for
examination and to make the most of the abilities of 3D-STE.
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